Neurology Central

SfN17: Neurodegeneration and the microbiome – new research highlights

New research presented today at the Society for Neuroscience’s annual conference, Neuroscience (Washington DC, USA; 11–15 November 2017), has indicated a role for the microbiome in neurodegenerative disease and pointed towards new treatments for Parkinson’s and Alzheimer’s diseases (PD and AD, respectively).

Speaking about five key studies highlighted by the Society (summarized below), Tracy Bale (University of Maryland School of Medicine, MD, USA) said: “The results presented today add to the growing body of evidence showing the influence of the gut on the brain and the crucial relationship between the two. Targeting the gut introduces a different and promising angle to tackle brain disorders across the lifespan.”

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.